EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Babin-Ebell, J.
Right arrow Articles by Elert, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Babin-Ebell, J.
Right arrow Articles by Elert, O.

European Journal of Cardio-Thoracic Surgery, Vol 10, 412-416, Copyright © 1996 by European Association for Cardio-thoracic Surgery


ARTICLES

Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting

J Babin-Ebell, PR Keith and O Elert
Department of Cardiothoracic Surgery, University of Wurzburg, Germany.

OBJECTIVE: Supraventricular tachyarrhythmias (SVT) complicate postoperative management after coronary bypass surgery in about 30% of all patients. Though a prophylactic treatment both with beta-adrenergic blocking agents and the calcium antagonist diltiazem has been used for the prevention of post-operative SVT, no study yet has performed a prospective comparison of the efficacy of these therapies. METHODS: To investigate the prophylactic effect of either a calcium antagonist (diltiazem, 0.1 mg/kg per h i.v.) or a beta-adrenergic blocking agent (propranolol, 10 mg every 6 h postoperatively), we randomized prospectively 103 consecutive patients into three groups, the third one serving as a control group. Anti-arrhythmic medication was started with the procedure and was continued until the 3rd postoperative day. RESULTS: Preoperative conditions were the same for the three groups concerning age, extent of coronary heart disease, ventricular function and heart-related medication. There were no differences in intraoperative parameters or postoperative enzyme patterns. Diltiazem was ineffective in preventing SVT, the incidence being exactly the same as in the control group (35%). Propranolol reduced the occurrence of SVT significantly (7%, P < 0.05). Furthermore, patients treated with diltiazem needed positive inotropic support more often in the first hours after surgery than patients of the control group (30% vs 5%, P < 0.01). CONCLUSIONS: The perioperative administration of low-dose propranolol is considered a safe and effective drug prophylaxis to avoid the occurrence of SVT after bypass surgery.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
W. L Baker and C M. White
Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies
Ann. Pharmacother., April 1, 2007; 41(4): 587 - 598.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
F. Wiesbauer, O. Schlager, H. Domanovits, B. Wildner, G. Maurer, M. Muellner, H. Blessberger, and M. Schillinger
Perioperative {beta}-Blockers for Preventing Surgery-Related Mortality and Morbidity: A Systematic Review and Meta-Analysis
Anesth. Analg., January 1, 2007; 104(1): 27 - 41.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. C. Burgess, M. J. Kilborn, and A. C. Keech
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis
Eur. Heart J., December 1, 2006; 27(23): 2846 - 2857.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud
Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 39S - 47S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Sanjuan, M. Blasco, N. Carbonell, A. Jorda, J. Nunez, J. Martinez-Leon, and E. Otero
Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery
Ann. Thorac. Surg., March 1, 2004; 77(3): 838 - 843.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R A Archbold and R J Schilling
Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature
Heart, February 1, 2004; 90(2): 129 - 133.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. N. Wijeysundera, W. S. Beattie, V. Rao, and J. Karski
Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1496 - 1505.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Crystal, S. J. Connolly, K. Sleik, T. J. Ginger, and S. Yusuf
Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery: A Meta-Analysis
Circulation, July 2, 2002; 106(1): 75 - 80.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
V. Piriou, A. Aouifi, and J.J. Lehot
Interet des beta-bloquants en medecine perioperatoire. Deuxieme partie: indications therapeutiques
Can J Anesth, July 1, 2000; 47(7): 664 - 672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.